Cogstate Limited (ASX:CGS)

Market Cap	371.56M
Revenue (ttm)	80.98M
Net Income (ttm)	15.47M
Shares Out	171.22M
EPS (ttm)	0.09
PE Ratio	24.40
Forward PE	23.97
Dividend	0.02 (0.92%)
Ex-Dividend Date	Aug 27, 2025

Volume	50,251
Average Volume	310,177
Open	2.170
Previous Close	2.170
Day's Range	2.140 - 2.200
52-Week Range	0.860 - 2.200
Beta	-0.36
RSI	74.94
Earnings Date	Aug 22, 2025

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.

Financial numbers in USD